13F Holdings
中文EN

EBRCZ EBR Systems, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1347123 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-45.6%
TTM EPS YoY83.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin11.4%
Operating margin-737.5%
Net margin-774.5%
FCF margin-919.0%
EBITDA margin-726.4%

Returns

ROE-112.9%
ROA-51.7%
ROIC (approx.)-57.8%
Asset turnover0.07x

Leverage & solvency

Liabilities / assets47.8%
Debt / equity0.54x
Current ratio2.11x
Interest coverage-11.50x

Cash quality & payout

Operating cash flow / net income1.07x
Accruals ratio3.6%
Payout ratio—
Capex / revenue91.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.49M$2.64M$2.36M$935,203$512,000$170,000——
Cost of revenue$2.24M$2.29M$2.18M$753,354$288,000$85,000——
Gross profit$249,000$343,000$184,000$181,849$224,000$85,000——
R&D expense$6.70M$6.62M$6.42M$6.33M$6.24M$5.95M$5.42M$6.89M
SG&A expense$9.80M$10.12M$9.94M$7.15M$5.86M$5.26M$4.36M$2.93M
Operating income-$16.25M-$16.40M-$16.17M-$13.29M-$11.88M-$11.13M-$9.78M-$9.83M
Interest expense$1.36M$1.33M$1.32M$1.39M$1.43M$1.43M$1.40M$1.47M
Pretax income-$16.64M-$17.45M-$17.07M-$14.05M-$12.19M-$11.97M-$10.55M-$10.10M
Income tax———$2,000$0$0$0$1,535
Net income-$16.64M-$17.45M-$17.07M-$14.05M-$12.19M-$11.97M-$10.55M-$10.10M
EBITDA-$15.85M-$16.10M-$16.05M-$13.18M-$11.78M-$11.03M-$9.70M-$9.74M
EPS (basic)-0.21-0.35-0.38—-0.27-0.30-0.28—
EPS (diluted)-0.21-0.35-0.38—-0.27-0.30-0.28—
Weighted avg. shares (diluted)79.04M49.24M45.04M—44.97M39.59M37.25M—
Balance sheet
Cash & equivalents$13.98M$59.35M$6.56M$5.79M$15.25M$47.60M$11.50M$6.92M
Short-term investments$71.43M$26.59M$23.32M$47.40M$55.72M$36.70M$38.97M$53.75M
Receivables——————$29,276—
Inventory$18.94M$17.59M$15.49M$13.79M$9.69M$5.13M$4.72M$1.39M
Current assets$110.85M$110.15M$54.04M$73.11M$82.23M$90.35M$53.48M$64.47M
PP&E, net$9.14M$9.20M$8.77M$5.48M$3.19M$3.01M$1.24M$795,000
Total assets$147.19M$138.68M$80.29M$97.23M$104.99M$114.93M$75.50M$73.56M
Current liabilities$52.54M$52.02M$12.07M$14.05M$10.35M$9.69M$6.73M$8.33M
Long-term debt$41.80M$41.80M$41.80M$41.80M$41.80M$41.80M$41.81M$41.84M
Total debt$41.80M$41.80M$41.80M$41.80M$41.80M$41.80M$41.81M$41.84M
Total liabilities$70.33M$69.82M$70.75M$71.64M$66.34M$65.23M$60.94M$49.20M
Shareholders' equity$76.85M$68.86M$9.54M$25.59M$38.65M$49.70M$14.56M$24.36M
Net debt$27.82M-$17.55M$35.24M$36.01M$26.55M-$5.80M$30.31M$34.92M
Shares outstanding84.55M75.33M45.06M45.03M449.89M449.55M372.90M371.08M
Cash flow statement
Operating cash flow-$17.25M-$17.19M-$20.25M-$15.01M-$13.14M-$11.48M-$13.56M-$10.99M
Capital expenditure$87,000$2.85M$3.29M$1.46M$1.28M$889,000$60,000$65,539
Free cash flow-$17.34M-$20.05M-$23.54M-$16.47M-$14.42M-$12.37M-$13.62M-$11.05M
Investing cash flow-$51.52M-$6.18M$20.88M$8.12M-$19.08M$896,000$17.91M-$21.17M
Financing cash flow$23.38M$76.19M$132,000$57,311-$138,000$46.67M$242,000$2.68M
Depreciation & amortization$400,000$300,000$125,000$115,000$100,000$100,000$79,000$90,641
Stock-based compensation$1.00M$936,000$907,000$912,864$929,000$704,000$505,000$486,253

Free plan shows the latest 8 periods; Pro shows all 15 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.